A phase I dose escalation and pharmacokinetic trial of intra-vesical gemcitabine in the treatment of recurrent superficial transitional cell carcinoma of the bladder

By Maddineni S.   Sangar V.   King H.   Betts C.   O'Flynn K.   Lupton E.   George N.   Ramani V.   Clarke N.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 192-192

Elsevier

Access to resources Recommend Favorite

Metastatic Transitional Cell Carcinoma of the Ovary from Superficial Bladder Tumour

By Kardar Abdul H.   Lindstedt Eric M.   Tulbah Asma M.   Bazarbashi Shouki N.   Al Suhaibani Hamad S.  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 1, 1998-05 ,pp. : 73-76

Informa Healthcare

Access to resources Recommend Favorite

Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder

By Dearing Jonathan  

Annals of The Royal College of Surgeons of England, Vol. 87, Iss. 2, 2005-03 ,pp. : 85-87

The Royal College of Surgeons of England

Access to resources Recommend Favorite

Does angiogenesis predict recurrence in superficial transitional cell carcinoma of the bladder?

By Sagol O.   Yorukoglu K.   Sis B.   Tuna B.   Ozer E.   Guray M.   Mungan U.   Kirkali Z.  

Urology, Vol. 57, Iss. 5, 2001-05 ,pp. : 895-899

Elsevier

Access to resources Recommend Favorite

Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study

By Berger A.P.   Steiner H.   Stenzl A.   Akkad T.   Bartsch G.   Holtl L.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 338-341

Elsevier

Access to resources Recommend Favorite